Literature DB >> 1525255

A sensitive method for the assay of serum prolyl endopeptidase.

F Goossens1, I De Meester, G Vanhoof, S Scharpé.   

Abstract

A new fluorimetric assay for the determination of prolyl endopeptidase (EC 3.4.21.26) was developed. The synthetic substrate Z-glycyl-prolyl-4-methylcoumarinyl-7-amide (0.2 mmol/l; 5 microliters), K-phosphate buffer (100 mmol/l, pH 7.5; 100 microliters), and serum (10 microliters) are incubated for 120 min at 37 degrees C. The reaction is stopped with acetic acid (1.5 mol/l; 500 microliters) and the released 7-amino-4-methylcoumarin is measured fluorimetrically. The mean value of prolyl endopeptidase catalytic activity concentration in serum for 120 healthy volunteers was 0.455 (SD = 0.092) mumol of 7-amino-4-methylcoumarin released per litre of serum per minute. The proposed procedure is sensitive, robust, and economical.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525255

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  10 in total

1.  Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown.

Authors:  Saskia Braber; Pim J Koelink; Paul A J Henricks; Patricia L Jackson; Frans P Nijkamp; Johan Garssen; Aletta D Kraneveld; J Edwin Blalock; Gert Folkerts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-26       Impact factor: 5.464

2.  Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.

Authors:  K N Lee; K W Jackson; V J Christiansen; E K Dolence; P A McKee
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

3.  Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.

Authors:  P Morain; J L Robin; G De Nanteuil; R Jochemsen; V Heidet; D Guez
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

4.  Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

Authors:  Marie-Berthe Maes; Anne-Marie Lambeir; Kambiz Gilany; Kristel Senten; Pieter Van der Veken; Barbara Leiting; Koen Augustyns; Simon Scharpé; Ingrid De Meester
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 5.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

6.  A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.

Authors:  D Clark Files; Kevin W Gibbs; Christopher L Schaich; Sean P Collins; TanYa M Gwathmey; Jonathan D Casey; Wesley H Self; Mark C Chappell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

7.  Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders.

Authors:  Naghi Momeni; Berit M Nordström; Vibeke Horstmann; Hassan Avarseji; Bengt V Sivberg
Journal:  BMC Psychiatry       Date:  2005-06-02       Impact factor: 3.630

8.  Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.

Authors:  Kenneth W Jackson; Victoria J Christiansen; Vivek R Yadav; Robert Silasi-Mansat; Florea Lupu; Vibhudutta Awasthi; Roy R Zhang; Patrick A McKee
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

9.  Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.

Authors:  André Steven; Sandra Leisz; Claudia Wickenhauser; Kristin Schulz; Dimitrios Mougiakakos; Rolf Kiessling; Carsten Denkert; Barbara Seliger
Journal:  Oncotarget       Date:  2017-10-27

10.  Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2).

Authors:  Gwendolyn Vliegen; Kaat Kehoe; An Bracke; Emilie De Hert; Robert Verkerk; Erik Fransen; Bart 's Jongers; Esther Peters; Anne-Marie Lambeir; Samir Kumar-Singh; Peter Pickkers; Philippe G Jorens; Ingrid De Meester
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.